Live Breaking News & Updates on Tsetis Pharmaceutical Group

Stay updated with breaking news from Tsetis pharmaceutical group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

International collaborations and sustainability on top of Tseti's agenda


ANALYSIS/OPINION:
Kleon Tsetis, a restless pharmacist and researcher, with a vision to strengthen the position of Greek manufacturing in the pharmaceutical industry, established Uni-Pharma in 1963 with the mission to improve the quality of life of our fellow men by facilitating access to treatment with innovative, high-quality and cost-efficient pharmaceutical products. “Since its establishment, Uni-pharma has been active in research, development, manufacturing and marketing of pharmaceuticals of the highest quality, covering all major therapeutic areas, with innovative, ground-breaking products of their time, such as IV paracetamol, APOTEL and enteric-coated low-dose ASA, SALOSPIR, as well as technologically challenging products such as Levothyroxine Sodium, T4” explained Mrs. Julia Tseti, CEO of The Tsetis Pharmaceutical Group of Companies (OFET). ....

United States , Julia Tseti , Tsetis Pharmaceutical Group Of Companies , Our Group , Washington Times , Levothyroxine Sodium , Tsetis Pharmaceutical Group , Joint Venture , ஒன்றுபட்டது மாநிலங்களில் , அவர் குழு , வாஷிங்டன் முறை , கூட்டு துணிகர ,